Lactobacillus crispatus LV5 and Reduced Sore Throat Severity

• Lactobacillus crispatus DSM25988 as novel bioactive agent to co-aggregate Streptococcus pyogenes and to exclude it by binding to human cells.

  • 2022-02-28
  • Beneficial Microbes 13(1)
  • • A. Reiprich
    • L. Skalden
    • A. Raab
    • N. Bolotina
    • C. Lang

  • PubMed: 35144524
  • DOI: 10.3920/BM2021.0103

  6 Insights on

  • Reduced Sore Throat Severity

  • Low evidence

  The study data shows promising safety and efficacy of the medical device when used against symptoms of sore throat like scratchy feeling, hoarse voice and swallowing pain.

  • Beneficial
  • Moderate effect